{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T10:23:21Z","timestamp":1766312601465,"version":"3.41.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpsychores.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychosomatic Research"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jpsychores.2015.03.005","type":"journal-article","created":{"date-parts":[[2015,3,15]],"date-time":"2015-03-15T00:00:44Z","timestamp":1426377644000},"page":"579-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Social support decreases depressogenic effect of low-dose interferon alpha treatment in melanoma patients"],"prefix":"10.1016","volume":"78","author":[{"given":"P\u00e9ter","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitta","family":"P\u00e1ncz\u00e9l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00edmea","family":"Balatoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Liszkay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xenia","family":"Gonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyorgy","family":"Bagdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Juhasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychores.2015.03.005_bb0005","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.ejca.2012.06.013","article-title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline \u2014 Update","volume":"48","author":"Garbe","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0010","first-page":"466","article-title":"Dose-dependent development of depressive symptoms during adjuvant interferon treatment of patients with malignant melanoma","volume":"51","author":"Friebe","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0015","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/annonc\/mdn001","article-title":"Adjuvant low-dose interferon alpha 2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis","volume":"19","author":"Garbe","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0020","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/archdermatol.2009.308","article-title":"Psychological responses and coping strategies among patients with malignant melanoma","volume":"145","author":"Kasparian","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0278-5846(01)00324-4","article-title":"Interferon (IFN) and psychiatric syndromes: a review","volume":"26","author":"Schaefer","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0030","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1176\/appi.ajp.2007.06122007","article-title":"The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults","volume":"164","author":"Kilpatrick","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/pon.3060","article-title":"Psychosocial aspects of post-treatment follow-up for stage I\/II melanoma: a systematic review of the literature","volume":"22","author":"Rychetnick","year":"2012","journal-title":"Psychooncology"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2011.09.061","article-title":"Interferon modulates central nervous system function","volume":"1442","author":"Reyes-Vazquez","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0045","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2010.04.011","article-title":"Glucocorticoids, cytokines and brain abnormalities in depression","volume":"35","author":"Zunszain","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0165-0327(00)00174-9","article-title":"The evolution of life events research in psychiatry","volume":"62","author":"Paykel","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: moderation by a polimorphism in the 5-HTT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with Citalopram for depression using measurement-based care in STAR-D implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/pon.656","article-title":"The association between social support, intrusive thoughts, avoidance, and adjustment following an experimental cancer treatment","volume":"12","author":"Devine","year":"2003","journal-title":"Psychooncology"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/PSY.0b013e3181ce6a7d","article-title":"Social influences on health: is serotonin a critical mediator?","volume":"72","author":"Way","year":"2010","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0075","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s12253-014-9777-7","article-title":"Psychological changes in melanoma patients during ipilimumab treatment compared to low-dose interferon alpha therapy\u2014a follow-up study of first experiences","volume":"20","author":"Kov\u00e1cs","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0085","series-title":"A pszichi\u00e1tria magyar k\u00e9zik\u00f6nyve","article-title":"Diagnosztikus k\u00e9rd\u0151\u00edvek \u00e9s t\u00fcnetbecsl\u0151 sk\u00e1l\u00e1k","author":"\u00c1goston","year":"2009"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0090","series-title":"Cross-Cultural Anxiety","first-page":"51","article-title":"The development and validation of the Hungarian Form of the STAI","author":"Sipos","year":"1978"},{"year":"1983","series-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","key":"10.1016\/j.jpsychores.2015.03.005_bb0095"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0146167287131001","article-title":"Stress-moderating effects: social support in the context of gender and locus of control","volume":"13","author":"Caldwell","year":"1987","journal-title":"Pers Soc Psychol Bull"},{"year":"1995","series-title":"Magyar lelki\u00e1llapot","author":"Kopp","key":"10.1016\/j.jpsychores.2015.03.005_bb0105"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0110","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/pon.1976","article-title":"The nature and structure of psychological distress in people at high risk for melanoma: a factor analytic study","volume":"21","author":"Kasparian","year":"2012","journal-title":"Psychooncology"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0115","series-title":"AJCC Cancer Staging Manual","first-page":"325","article-title":"Melanoma of the skin","author":"Edge","year":"2010"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0120","first-page":"230","article-title":"A melanoma malignum diagnosztik\u00e1ja \u00e9s ter\u00e1pi\u00e1ja napjainkban","volume":"2","author":"Liszkay","year":"2012","journal-title":"Onkol\u00f3gia"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0125","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1002\/cncr.24561","article-title":"Depression as a predictor of disease progression and mortality in cancer patients","author":"Satin","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/CJI.0b013e3181b8bdb9","article-title":"Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon alpha treatment in patients with malignant melanoma","volume":"33","author":"Heinze","year":"2010","journal-title":"J Immunother"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1099-1611(199901\/02)8:1<14::AID-PON321>3.0.CO;2-E","article-title":"The role of religious and spiritual beliefs in coping with malignant melanoma","volume":"8","author":"Holland","year":"1999","journal-title":"Psychooncology"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","article-title":"Neuropsychiatric adverse effects of interferon alpha","volume":"19","author":"Raison","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0145","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.mp.4002006","article-title":"The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression","volume":"12","author":"M\u00fcller","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.genhosppsych.2010.03.001","article-title":"Can antidepressants prevent interferon alpha-induced depression? A review of the literature","volume":"32","author":"Almeida","year":"2010","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0155","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by highdose interferon alpha","volume":"344","author":"Musselmann","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0160","first-page":"213","article-title":"A new clinical evidence-based gene\u2013environment interaction model of, depression","volume":"14","author":"Bagdy","year":"2012","journal-title":"Neuropsychopharmacol Hung"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0165","first-page":"1","article-title":"Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing","author":"Mostafavi","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0170","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0031-6997(25)06673-6","article-title":"Physiology and pharmacology of corticotropin-releasing factor","volume":"43","author":"Owens","year":"1991","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0175","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/mp.2008.58","article-title":"Interferon alpha effects on diurnal hypotalamic\u2013pituitary\u2013adrenal axis activity: relationship with proinflammatory cytokines and behavior","volume":"15","author":"Raison","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.03.005_bb0180","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1037\/a0032671","article-title":"Psychobiological mechanisms underlying the social buffering of the hypothalamic\u2013pituitary\u2013adrenocortical axis: a review of animal models and human studies across development","volume":"140","author":"Hostinar","year":"2014","journal-title":"Psychol Bull"}],"container-title":["Journal of Psychosomatic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399915000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399915000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:10:17Z","timestamp":1747786217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022399915000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0022399915000598"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychores.2015.03.005","relation":{},"ISSN":["0022-3999"],"issn-type":[{"type":"print","value":"0022-3999"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Social support decreases depressogenic effect of low-dose interferon alpha treatment in melanoma patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychosomatic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychores.2015.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}